市場調査レポート
商品コード
1439362
動力手術器具 - 世界市場の考察、競合情勢、市場予測(2030年)Powered Surgical Instrument - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
動力手術器具 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の動力手術器具の市場規模は、2023年に20億6,000万米ドル、2030年までに26億5,000万米ドルに達し、2024年~2030年の予測期間にCAGRで4.26%の成長が見込まれます。変性骨疾患や眼科疾患の有病率の増加をもたらす高齢化の進行、脳腫瘍の増加、外傷症例の増加、製品革新の成長などの要因が、動力手術器具市場の成長を積極的に刺激しています。
動力手術器具の市場力学
動力手術器具市場の積極的な成長を支える要因のうち、大きな理由の1つが老年人口の増加です。国連の「World Population Ageing 2020 Highlights」によると、2020年の世界の65歳以上の人口は約7億2,700万人です。前述の資料はさらに、老年人口は30年後には15億人以上に倍増すると予測しています。老年人口は、加齢に伴う目の疾患や骨の変性疾患などのさまざまな疾患を発症しやすいです。International Osteoporosis Foundation(2023年)によると、骨粗鬆症に関連した骨折は年間890万件以上発生しています。さらに、50歳以上の男性の約5人に1人、女性の3人に1人が骨が弱いために骨折しやすいと述べています。骨粗鬆症は一般的な変性性骨疾患の1つで、骨量が減少したり、骨の構成が減少したりします。骨粗鬆症の骨は密度が低くなり、弱くなり、骨折しやすくなります。したがって、変性骨疾患の有病率の増加は、動力手術器具が多用される整形外科手術の需要を増加させ、それが予測期間(2024年~2030年)の動力手術器具市場の成長を促進すると予測されます。
動力手術器具の需要を促進するもう1つの要因は、世界中での脳腫瘍の有病率の上昇です。世界保健機関(WHO)が引用した2020年のGLOBOCANの調査によると、2020年、世界全体で脳と中枢神経系のがんが新たに約30万8,102件発生しました。中枢神経系のがんは死亡率や転移率が高いです。そのため、動力手術器具を必要とする腫瘍を切除するために、数多くの種類の脳手術が行われています。したがって、今後数年間における脳腫瘍とCNSがんの増加は、動力手術器具の需要拡大に寄与し、予測期間の動力手術器具市場の成長をもたらす可能性があります。
しかし、取り付けられたワイヤーによって手術部位へのアクセスが抑制される従来の動力手術器具の複雑な設計や、再使用前に洗浄や滅菌が必要であることなどの要因が、動力手術器具市場の成長を阻害する可能性があります。
上記の要因に加えて、動力手術器具市場は、COVID-19の蔓延を食い止めるために必要な措置としてロックダウンが課されたため、一時的に後退した時期がありました。この間の主な措置の1つは、多数の選択的処置と外来受診の停止でした。この措置により、さまざまな医療専門部門にわたる多数の手術がロックダウン初期に中断されたため、市場における動力手術器具の需要が減少し、それによって市場の成長が短期間制限されました。とはいえ、動力手術器具市場は、世界中で多数のCOVID-19ワクチンが承認および投与されたことにより、医療サービスを含むさまざまな領域で活動が再開され、回復期にあります。
動力手術器具市場のセグメント分析
動力源別では、動力手術器具市場において、バッテリー駆動の動力手術器具が2024年~2030年の予測期間にもっとも速い成長を示すと予測されています。バッテリー駆動の電動工具は、使い勝手がよく、工具にリード線が付属していないため、採用が増加しています。さらに、バッテリーパックは過酸化水素ガス、酸化エチレンガス、ガンマ線などのさまざまな方法で滅菌できるため、感染の可能性を大幅に減らすことができます。したがって、これらの需要の増加が今後数年間の動力手術器具市場の全体的な成長に寄与すると予測されます。
北米が動力手術器具市場全体を独占すると予測されます。
全地域の中で、北米が動力手術器具市場で世界最大のシェアを獲得すると予測されます。関節炎やその他の骨疾患の高い有病率、老年人口の増加、再建手術や美容手術の増加、よりよい医療施設や償還プログラムの増加、主要市場企業のプレゼンス、研究開発活動への投資の増加などが、この地域における動力手術器具の予測期間における全体的な成長を促進する主な影響要因になると予測されています。
当レポートでは、世界の動力手術器具市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Powered Surgical Instruments Market By Product Type (Handpieces [Drills, Saws, Reamers, Shavers And Others], Power Consoles And Controls, And Others), By Power Source (Pneumatic, Battery-Powered, And Electric), By Application (Orthopedic Surgery, Neurosurgery, ENT Surgery, Ophthalmic Surgery, Cardiac Surgery, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing volume of surgical procedures due to rise in incidence of bone fractures and various cancers.
Global Powered Surgical Instruments Market was valued at USD 2.06 billion in 2023, growing at a CAGR of 4.26% during the forecast period from 2024 to 2030 to reach USD 2.65 billion by 2030. Factors such as rising aging population resulting in the increasing prevalence of degenerative bone disorders and ophthalmic conditions, rising number of brain cancers, increasing number of trauma cases, and growth in the product innovation are stimulating the growth of the powered surgical instruments market positively.
Powered Surgical Instruments Market Dynamics:
One of the main reasons among the other key factors behind the positive growth of the powered surgical instruments market is the rising geriatric population. According to the United Nations World Population Ageing 2020 Highlights, there were about 727 million people over the age of 65 worldwide in 2020. The aforementioned source further mentioned that the elderly population is expected to double to more than 1.5 billion in three decades. The elderly population is prone to the development of various diseases such as various age-related disorders such as age-related eye conditions and degenerative bone diseases among others. As per the International Osteoporosis Foundation (2023), over 8.9 million fractures related to osteoporosis occur annually. It further stated that about one in five men and one in three women over the age of 50 are susceptible to suffer from a fracture due to weak bones. Osteoporosis is one of the common degenerative bone disease where the body starts to lose bone mass or there is a reduction in the formation of bone. The osteoporotic bones become less dense, become weak, and are more prone to fractures. Thus, the increasing prevalence of degenerative bone conditions is expected to increase the demand for orthopedic surgeries where powered surgical tools are heavily employed thereby driving the powered surgical instruments market growth during the forecast period (2024-2030).
Another factor driving the demand for powered surgical tools is the rising prevalence of brain cancers across the globe. As per the GLOBOCAN study for 2020 cited by the World Health Organization, in 2020, there were about 308,102 new cases of brain and central nervous system cancers globally. Cancers of CNS have high mortality and metastatic rates associated with them. Therefore, numerous types of brain surgeries are performed for excising the tumors which require the use of powered surgical devices. Therefore, the increasing number of brain and CNS cancers in the coming years would contribute in the growing demand for powered surgical devices, thereby resulting in the growth of the powered surgical instruments market during the forecast period.
However, factors such as the complex designs of the conventional powered surgical instruments that restrict the access of the area to be operated due to attached wires and the requirement for cleaning and sterilization before being reused may inhibit the growth for powered surgical instruments in the market.
Along with the above-mentioned factors, the powered surgical instruments market witnessed a period of temporary setback due to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for powered surgical instruments in the market as a large number of surgeries across different medical specialties were suspended during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for powered surgical instruments is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the powered surgical instruments market during the forecast period from 2024-2030.
Powered Surgical Instruments Market Segment Analysis:
Powered Surgical Instruments Market by Product Type (Hand pieces [Drills, Saws, Reamers, Shavers and Others], Power Consoles and Controls, and Others), by Power Source (Pneumatic, Battery-Powered, and Electric), by Application (Orthopedic Surgery, Neurosurgery, ENT Surgery, Ophthalmic Surgery, Cardiac Surgery, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Based on power source, in the powered surgical instruments market, the battery-powered powered surgical instruments are predicted to witness the fastest growth during the forecast period from 2024-2030. The adoption of battery-driven power tools is increasing as these devices are convenient to use and have no lead attached to the tool. Moreover, battery packs can be sterilized by various methods such as hydrogen peroxide gases, ethylene oxide gases, and gamma rays which reduces the chances of infections significantly. Therefore, their increased demand is expected to contribute in the overall growth of the powered surgical instruments market growth in the coming years.
North America is expected to dominate the Overall Powered Surgical Instruments Market:
Among all the regions, North America is expected to amass the largest share of powered surgical instruments market globally. The growing number of orthopedic surgical procedures owing to the high prevalence of arthritis and other bone diseases, rising population of the elderly, increasing number of reconstructive and cosmetic surgeries well as better healthcare facilities and reimbursement programs coupled with the presence of major market players as well as higher investment in the research and development activities in the region are predicted to be the major influencing factors in driving the overall growth of the powered surgical instruments over the forecast period.
In North America, the US is expected to account for the largest share in North America Powered Surgical Instruments market. This can be attributed to the increasing cases of bone-related disorders in the country. As per the data provided by the US Centers for Disease Control and Prevention (2018), it has been estimated that by 2025, 67 million people in the country will have doctor-diagnosed arthritis and it is expected to reach 78 million by 2045. This increase in the diseases population affected with arthritis would lead to the increased number of orthopedic surgeries in the country which in turn will contribute in the increasing demand for powered surgical instruments thereby aiding in the growth of the powered surgical instruments market in the country and as well as the region.
Moreover, as per the Plastic Surgery Statistics Report published by the American Society of Plastic Surgeons, in 2020, in the United States approximately 15.6 million procedures were performed. The report further stated that in 2020, maxillofacial surgery, tumor removal, scar revision, laceration repair, and hand surgery were the top five reconstructive procedures. These procedures require the use of powered surgical devices in order to access the area of interest. Therefore, the rising popularity of plastic and reconstructive procedures is also expected to drive the demand for powered surgical instruments in the country, thereby providing a conducive environment for the growth of the United States powered surgical instruments market, and in North America during the forecast period.
Along with the factors mentioned above, the large presence of key market players as well as the launch of new products in the region as a reason of extensive R&D activities also provide favorable conditions for the growth of the North American powered surgical instruments market.
For instance, in November 2020, Medtronic received the 510k product approval from the US Food and Drug Administration for the Midas Rex Attachments and Dissecting Tools. These tools are intended to be used for the incision/cutting, drilling, burring, and removal of hard tissue and bone in open and minimally invasive spine procedures. The local launch of the products in the regional market also provides an added advantage for both end users and manufacturers as the product cost in significantly reduced resulting in their high uptake.
Therefore, the interplay of various factors such as the presence of large patient population, encouraging reimbursement policies as well as new product launches in the region are going to boost the North America powered surgical instruments market during the forecast period.
Powered Surgical Instruments Market Key Players:
Some of the key market players operating in the powered surgical instruments market includes Stryker, CONMED Corporation, Medtronic, DePuy Synthes (Medical Devices Business Services, Inc.), MicroAire Surgical Instruments, LLC, Zimmer Biomet, De Soutter Medical, adeor medical AG, Smith & Nephew, Arthrex Inc, Inc, Brasseler USA, Nouvag AG, AYGUN CO.,INC, iMEDICOM, Shanghai Bojin Medical Instrument Co.,Ltd, ORTHOPROMED, Allotech Co. Ltd., medical bees GmbH, MatOrtho Limited, NAKANISHI INC, Kaiser Medical Technology, and others.
Recent Developmental Activities in Powered Surgical Instruments Market:
In June 2022, Stryker received the 510k approval from the US Food and Drug Administration for their Stryker iBur hubs and cutting accessories which are intended to be used with the Stryker Core Consolidated Operating Room (CORE) Console and electric and pneumatic motors.
In June 2022, Zethon Ltd received the 510k approval from the US Food and Drug Administration for their hekaDrill for use in the incisions, drilling, sawing of soft and hard bone tissue.
In April 2022, adeor medical AG received the 510k approval from the US Food and Drug Administration for their Velocity Alpha High speed Surgical Drill System for rapid cutting, sawing, drilling and manipulation of soft tissue and bone.
Key Takeaways from the Powered Surgical Instruments Market Report Study
Market size analysis for powered surgical instruments market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the powered surgical instruments market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global powered surgical instruments market.
Various opportunities available for the other competitor in the powered surgical instruments market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current powered surgical instruments market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for powered surgical instruments market growth in the coming future?
Target Audience who can be benefited from this Powered Surgical Instruments Market Report Study
Powered Surgical Instruments products providers
Research organizations and consulting companies
Powered Surgical Instruments -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in powered surgical instruments
Various End-users who want to know more about the powered surgical instruments market and latest technological developments in the powered surgical instruments market.
Frequently Asked Questions for Powered Surgical Instruments Market:
A surgical power tool is an equipment which is used to perform surgery on bone or bone fragments in different anatomical locations in the body. These tools help in sawing, drilling, screwing, and reaming.
Global Powered Surgical Instruments Market was valued at USD 2.06 billion in 2023, growing at a CAGR of 4.26% during the forecast period from 2024 to 2030 to reach USD 2.65 billion by 2030.
The major drivers of the global powered surgical instruments market are the rising aging population, rising number of brain cancers, increasing number of trauma cases, and growth in the product innovation are stimulating the growth of the powered surgical instruments market positively.
Some of the key market players operating in the powered surgical instruments market includes Stryker, CONMED Corporation, Medtronic, DePuy Synthes (Medical Devices Business Services, Inc.), MicroAire Surgical Instruments, LLC, Zimmer Biomet, De Soutter Medical, adeor medical AG, Smith & Nephew, Arthrex Inc, Inc, Brasseler USA, Nouvag AG, AYGUN CO.,INC, iMEDICOM, Shanghai Bojin Medical Instrument Co.,Ltd, ORTHOPROMED, Allotech Co. Ltd., medical bees GmbH, MatOrtho Limited, NAKANISHI INC, Kaiser Medical Technology, and others.
Among all the regions, North America is expected to amass the largest share of powered surgical instruments market. The growing number of orthopedic surgical procedures owing to the high prevalence of arthritis and other bone diseases, rising population of the elderly, increasing number of reconstructive and cosmetic surgeries well as better healthcare facilities and reimbursement programs coupled with the presence of major market players as well as higher investment in the research and development activities in the region are predicted to be the major influencing factors in driving the overall growth of the powered surgical instruments over the forecast period.